According to the Aβ hypothesis, the accumulation of the neurotoxic Aβ initiates the downstream processes, leading to AD pathologies such as tau aggregation, loss of neurons, and synaptic connections (Hardy and Higgins, 1992; Selkoe and Hardy, 2016; Karran and de Strooper, 2022). Here, MAPT is linked to Alzheimer disease.